Aprotinin use linked to renal, CV and cerebrovascular AEs

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1087, 2006-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inconclusive findings for aprotinin in paediatric renal impairment

By  

Reactions Weekly, Vol. 1, Iss. 1190, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Clinical Experience with the Use of Angiotensin Receptor Blockers in Patients with Cardiovascular, Cerebrovascular and Renal Diseases

By  

Current Clinical Pharmacology, Vol. 1, Iss. 2, 2006-05 ,pp. : 139-146

Bentham Science Publishers

Access to resources Recommend Favorite

Aprotinin guidelines improve use, reduce expenditure

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Renal dysfunction possible with aprotinin during off-pump surgery

By  

Reactions Weekly, Vol. 1, Iss. 1189, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Renal dysfunction possible with aprotinin during off-pump surgery

By  

Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite